Robatumumab (Anti-IGF1R / CD221), 1mg*5

Robatumumab (Anti-IGF1R / CD221), 1mg*5

Anti-CYR61 / CCN1, 1mg

Anti-CYR61 / CCN1, 1mg

Robatumumab (Anti-IGF1R / CD221), 1mg*25

19.336,31 RON
SKU
SKM_A3044_1mg*25

Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD